公司概覽
業務類別 Biotechnology
業務概覽 Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
公司地址 215 First Street, Suite 415, Cambridge, MA, USA, 02142
電話號碼 +1 617 274-4000
傳真號碼 +1 800 621-5203
公司網頁 https://www.sarepta.com
員工數量 835
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Michael Severino, M.D. Chief Executive Officer and Director -- 27/07/2026
Dr. Louise Rodino-Klapac, PhD President, Research and Development and Technical Operations 美元 752.51K 24/04/2026
Mr. Ian Michael Estepan President and Chief Operating Officer 美元 740.53K 24/04/2026
Ms. Cristin L. Rothfuss Executive Vice President, Chief General Counsel and Corporate Secretary 美元 629.86K 24/04/2026
Mr. Ryan H. Wong Executive Vice President, Chief Financial Officer and Principal Accounting Officer 美元 480.12K 24/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. Deirdre P. Connelly Independent Director 24/04/2026
Dr. M. Kathleen Behrens Wilsey, PhD Chairwoman of the Board 24/04/2026
Dr. Claude Nicaise,M.D. Independent Director 24/04/2026
Dr. Hans Wigzell, M.D.,PhD Independent Director 24/04/2026
Mr. Richard J. Barry Independent Director 24/04/2026
Dr. Michael Severino, M.D. Chief Executive Officer and Director 27/07/2026
Dr. Kathryn Jean Boor, PhD Independent Director 24/04/2026
Dr. Stephen L. Mayo, PhD Independent Director 24/04/2026
Mr. Michael A. Chambers Independent Director 24/04/2026
 
所屬ETF (更新日期: 14/11/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
VIOGVanguard S&P Small-Cap 600 Growth ETF0.07%30/09/2026
VFVAVanguard US Value Factor ETF0.07%30/09/2026
IWOiShares Russell 2000 Growth ETF0.06%30/10/2026
PRFInvesco RAFI US 1000 ETF0.06%30/10/2026
SCHBSchwab US Broad Market ETF0.06%31/10/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.05%30/10/2026
FELVFidelity Enhanced Large Cap Value ETF0.05%30/10/2026
JMEEJPMorgan Small & Mid Cap Enh Eq ETF0.05%30/10/2026
FHLCFidelity MSCI Health Care ETF0.05%30/10/2026
DFUSDimensional US Equity Market ETF0.03%30/10/2026
ONEQFidelity Nasdaq Composite ETF0.03%30/10/2026
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF0.03%30/10/2026
DFAUDimensional US Core Equity Market ETF0.03%30/10/2026
AVUSAvantis US Equity ETF0.02%30/10/2026
IWViShares Russell 3000 ETF0.02%30/10/2026
ESGVVanguard ESG US Stock ETF0.02%30/09/2026
ISCViShares Morningstar Small-Cap Value ETF0.02%30/10/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.02%30/10/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%30/10/2026
JCENuveen Core Equity Alpha0.02%30/09/2026
  1    2   3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.